Prostate cancer - Advantages and disadvantages of MR-guided RT

被引:54
作者
Murray, Julia
Tree, Alison C.
机构
[1] Royal Marsden NHS Fdn Trust, London, England
[2] Inst Canc Res, London, England
关键词
Prostate cancer; Radiotherapy; MRI; Daily adaptive replanning; RADIOTHERAPY; OUTCOMES;
D O I
10.1016/j.ctro.2019.03.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
External beam radiotherapy for prostate cancer is an optimal treatment choice for men with localised prostate cancer and is associated with long term disease control in most patients. Image-guided prostate radiotherapy is standard of care, however, current techniques can include invasive procedures with imaging of poor soft tissue resolution, thus limiting accuracy. MRI is the imaging of choice for local prostate cancer staging and in radiotherapy planning has been shown to reduce target volume and reduce inter-observer prostate contouring variability. The ultimate aim would be to have a MR-only workflow for prostate radiotherapy. Within this article, we discuss these opportunities and challenges, relevant due to the increasing availability of MR-guided radiotherapy. Prospective multi-centre studies are underway to determine the feasibility of MR-guided prostate radiotherapy and daily adaptive replanning. In parallel, development and adaptation of the existing radiotherapy multidisciplinary workforce is essential to enable an efficient and effective MR-guided radiotherapy workflow. This technology potentially provides us with the anatomical and biological information to further improve outcomes for our patients. (C) 2019 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.
引用
收藏
页码:68 / 73
页数:6
相关论文
共 30 条
[1]   Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer [J].
Catton, Charles N. ;
Lukka, Himu ;
Gu, Chu-Shu ;
Martin, Jarad M. ;
Supiot, Stephane ;
Chung, Peter W. M. ;
Bauman, Glenn S. ;
Bahary, Jean-Paul ;
Ahmed, Shahida ;
Cheung, Patrick ;
Tai, Keen Hun ;
Wu, Jackson S. ;
Parliament, Matthew B. ;
Tsakiridis, Theodoros ;
Corbett, Tom B. ;
Tang, Colin ;
Dayes, Ian S. ;
Warde, Padraig ;
Craig, Tim K. ;
Julian, Jim A. ;
Levine, Mark N. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (17) :1884-+
[2]   Relationship of Imaging Frequency and Planning Margin to Account for Intrafraction Prostate Motion: Analysis Based on Real-Time Monitoring Data [J].
Curtis, William ;
Khan, Mohammad ;
Magnelli, Anthony ;
Stephans, Kevin ;
Tendulkar, Rahul ;
Xia, Ping .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (03) :700-706
[3]   Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial [J].
Dearnaley, David ;
Syndikus, Isabel ;
Mossop, Helen ;
Khoo, Vincent ;
Birtle, Alison ;
Bloomfield, David ;
Graham, John ;
Kirkbride, Peter ;
Logue, John ;
Malik, Zafar ;
Money-Kyrle, Julian ;
O'Sullivan, Joe M. ;
Panades, Miguel ;
Parker, Chris ;
Patterson, Helen ;
Scrase, Christopher ;
Staffurth, John ;
Stockdale, Andrew ;
Tremlett, Jean ;
Bidmead, Margaret ;
Mayles, Helen ;
Naismith, Olivia ;
South, Chris ;
Gao, Annie ;
Cruickshank, Clare ;
Hassan, Shama ;
Pugh, Julia ;
Griffin, Clare ;
Hall, Emma .
LANCET ONCOLOGY, 2016, 17 (08) :1047-1060
[4]   Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial [J].
Dearnaley, David P. ;
Sydes, Matthew R. ;
Graham, John D. ;
Aird, Edwin G. ;
Bottomley, David ;
Cowan, Richard A. ;
Huddart, Robert A. ;
Jose, Chakiath C. ;
Matthews, John H. L. ;
Millar, Jeremy ;
Moore, A. Rollo ;
Morgan, Rachel C. ;
Russell, J. Martin ;
Scrase, Christopher D. ;
Stephens, Richard J. ;
Syndikus, Isabel ;
Parmar, Mahesh K. B. .
LANCET ONCOLOGY, 2007, 8 (06) :475-487
[5]   Assessment of cone beam CT registration for prostate radiation therapy: Fiducial marker and soft tissue methods [J].
Deegan, Timothy ;
Owen, Rebecca ;
Holt, Tanya ;
Fielding, Andrew ;
Biggs, Jennifer ;
Parfitt, Matthew ;
Coates, Alicia ;
Roberts, Lisa .
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2015, 59 (01) :91-98
[6]  
EU, EP PROST CANC EUR
[7]  
Fischer-Valuck BW, 2017, ADV RADIAT ONCOL, V2, P485, DOI 10.1016/j.adro.2017.05.006
[8]   The effect of hormonal treatment on conspicuity of prostate cancer: Implications for focal boosting radiotherapy [J].
Groenendaal, Greetje ;
van Vulpen, Marco ;
Pereboom, Susanne R. ;
Poelma-Tap, Davey ;
Korporaal, Johannes G. ;
Monninkhof, Evelyn ;
van der Heide, Uulke A. .
RADIOTHERAPY AND ONCOLOGY, 2012, 103 (02) :233-238
[9]   DOSE-VOLUME CONSTRAINTS TO REDUCE RECTAL SIDE EFFECTS FROM PROSTATE RADIOTHERAPY: EVIDENCE FROM MRC RT01 TRIAL ISRCTN 47772397 [J].
Gulliford, Sarah L. ;
Foo, Kerwyn ;
Morgan, Rachel C. ;
Aird, Edwin G. ;
Bidmead, A. Margaret ;
Critchley, Helen ;
Evans, Philip M. ;
Gianolini, Stefano ;
Mayles, W. Philip ;
Moore, A. Rollo ;
Sanchez-Nieto, Beatriz ;
Partridge, Mike ;
Sydes, Matthew R. ;
Webb, Steve ;
Dearnaley, David P. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03) :747-754
[10]  
Henderson D, 2018, MEDICINES, V5, P32